Literature DB >> 8590979

Alpha 2C-adrenoceptor-modulated release of noradrenaline in human right atrium.

L C Rump1, C Bohmann, U Schaible, J Schöllhorn, N Limberger.   

Abstract

1. The aim of the present study was to characterize the presynaptic alpha 2-autoreceptors in human right atrium in terms of the alpha 2A-D system. Segments of atrial appendages were preincubated with [3H]-noradrenaline and then superfused in the presence of cocaine and stimulated electrically. pEC30% values of eight alpha-adrenoceptor antagonists with discriminatory power were determined. pEC30% is the negative logarithm of the antagonist concentration that increased the stimulation-induced overflow of tritium by 30%. For four antagonists, the dissociation constant KD was determined, in addition to pEC30%, against the overflow-inhibiting effect of 5-bromo-6-(2-imidazolin-2-ylamino)-quinoxaline (UK 14,304) under autoinhibition-free conditions. 2. pEC30% and KD values yielded identical rank orders of antagonist affinity (rauwolscine > WB 4101 > phentolamine > prazosin) suggesting that both released noradrenaline and the exogenous agonist UK 14,304 activated the same receptor to inhibit release. 3. The eight antagonist pEC30% values obtained in right atrium correlated significantly with their pEC30% values, reported in the literature, at the presynaptic alpha 2C-autoreceptors in human kidney (r = 0.817; slope of the regression line 1.03). No significant correlation was obtained between pEC30% values at atrial autoreceptors and pKD values at previously characterized alpha 2A-autoreceptors in rabbit and alpha 2D-autoreceptors in rat, mouse and guinea-pig tissues. 4. Comparison of antagonist pEC30% values with their pKD values at native alpha 2 binding sites in cells or tissues that express a single subtype only, and with pKD values at alpha 2 binding sites in membranes of COS cells transfected with human alpha 2 subtype genes confirms the alpha 2C character of the atrial autoreceptors: significant correlations were obtained exclusively with the alpha 2C binding sites. 5. Ratios of KD values were computed for alpha 2-autoreceptors in human right atrium and for binding sites in COS cells transfected with human alpha 2 subtype genes. The autoreceptor ratios corresponded well with the respective ratios for the alpha 2C binding sites (maximal three fold deviation) but were, in part, markedly different from ratios calculated for alpha 2A and alpha 2B binding sites (up to 166 fold deviation). This outcome supports the alpha 2C designation of the autoreceptors. 6. In conclusion, the presynaptic alpha 2-autoreceptors in human right atrium are alpha 2C. In this they agree with the previously characterized alpha 2-autoreceptors in human kidney. The alpha 2C classification possibly separates, in general, human alpha 2-autoreceptors from those in lagomorph (rabbit) and rodent (rat, mouse, guinea pig) species that have been proposed to be predominantly alpha 2A or alpha 2D.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590979      PMCID: PMC1909128          DOI: 10.1111/j.1476-5381.1995.tb17216.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

Review 1.  Molecular biology of alpha-adrenergic receptors: implications for receptor classification and for structure-function relationships.

Authors:  J W Lomasney; S Cotecchia; R J Lefkowitz; M G Caron
Journal:  Biochim Biophys Acta       Date:  1991-10-26

Review 2.  Modulation of neurotransmitter release by presynaptic autoreceptors.

Authors:  K Starke; M Göthert; H Kilbinger
Journal:  Physiol Rev       Date:  1989-07       Impact factor: 37.312

3.  Inhibitory effects of clonidine on responses to sympathetic nerve stimulation in the pithed rat.

Authors:  J C Doxey; J Everitt
Journal:  Br J Pharmacol       Date:  1977-12       Impact factor: 8.739

Review 4.  Transmitter release from brain slices elicited by single pulses: a powerful method to study presynaptic mechanisms.

Authors:  E A Singer
Journal:  Trends Pharmacol Sci       Date:  1988-08       Impact factor: 14.819

5.  Subclassification of the presynaptic alpha 2-autoreceptors in rabbit brain cortex.

Authors:  N Limberger; L Späth; K Starke
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

6.  Differences between the alpha 2-adrenoceptor in rat submaxillary gland and the alpha 2A-and alpha 2B-adrenoceptor subtypes.

Authors:  A D Michel; D N Loury; R L Whiting
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

7.  Estimation of pA2 values at presynaptic alpha 2-autoreceptors in rabbit and rat brain cortex in the absence of autoinhibition.

Authors:  N Limberger; A Mayer; G Zier; B Valenta; K Starke; E A Singer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

8.  Subclassification of presynaptic alpha 2-adrenoceptors: alpha 2D-autoreceptors in mouse brain.

Authors:  N Limberger; A U Trendelenburg; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-07       Impact factor: 3.000

9.  Identification and characterization of alpha 2D-adrenergic receptors in bovine pineal gland.

Authors:  V Simonneaux; M Ebadi; D B Bylund
Journal:  Mol Pharmacol       Date:  1991-08       Impact factor: 4.436

10.  Functional evidence for heterogeneity of peripheral prejunctional alpha 2-adrenoceptors.

Authors:  S Connaughton; J R Docherty
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

View more
  3 in total

1.  Presynaptic imidazoline receptors and alpha 2-adrenoceptors in the human heart: discrimination by clonidine and moxonidine.

Authors:  J Likungu; G J Molderings; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

2.  Presynaptic alpha 2-autoreceptors in mouse heart atria: evidence for the alpha 2D subtype.

Authors:  C A Wahl; A U Trendelenburg; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

3.  Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors.

Authors:  Eckhard Schwertfeger; Thomas Klein; Oliver Vonend; Vitus Oberhauser; Johannes Stegbauer; Lars Christian Rump
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-22       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.